Literature DB >> 9559444

A comparison of young and aged populations for the diphtheria and tetanus antitoxin titers in Japan.

M Takahashi1, T Komiya, T Fukuda, Y Nagaoka, R Ishii, F Goshima, H Arimoto, H Kaku, N Nakajima, T Goshima, T Katoh.   

Abstract

The antitoxin levels for diphtheria and tetanus were measured with samples of a young group immunized with diphtheria-tetanus-acellular pertussis combined vaccine and those of an aged group, members of which had not received vaccination in their youth. In the young group members of which had already received basic immunization with diphtheria-tetanus-acellular pertussis combined vaccine, the levels of both antitoxins rose well after injection at 11 to 12 years old with diphtheria-tetanus combined toxoids and remained high until 20 years of age. In the aged group, more than 80% showed antitoxin levels above 0.01 u/ml for diphtheria, while all had levels below that for tetanus, except three persons with confirmed tetanus immunization history. Maintenance of the protective antitoxin levels in the population by vaccination is necessary to prevent outbreaks of infection among unvaccinated or only partially immunized persons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9559444     DOI: 10.7883/yoken1952.50.87

Source DB:  PubMed          Journal:  Jpn J Med Sci Biol        ISSN: 0021-5112


  2 in total

1.  Retrospective diagnosis of diphtheria by detection of the Corynebacterium diphtheriae tox gene in a formaldehyde-fixed throat swab using PCR and sequencing analysis.

Authors:  T Komiya; N Shibata; M Ito; M Takahashi; Y Arakawa
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).

Authors:  Jan Storek; Zhao Zhao; Eugene Lin; Thomas Berger; Peter A McSweeney; Richard A Nash; Yoshiki Akatsuka; Monja D Metcalf; Hailing Lu; Tomas Kalina; Markus Reindl; Rainer Storb; John A Hansen; Keith M Sullivan; George H Kraft; Daniel E Furst; David G Maloney
Journal:  Clin Immunol       Date:  2004-12       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.